-
Hot Alert: Enduro Royalty Trust (NYSE:NDRO), Baker Hughes Incorporated (NYSE:BHI), U.S. Silica Holdings (NYSE:SLCA), TAL International Group (NYSE:TAL), Amedisys Inc. (NASDAQ:AMED)
On 11 November Enduro Royalty Trust (NASDAQ:NDRO) posted its quarterly earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.24 by $0.02. On last trading day Enduro Royalty Trust (NYSE:NDRO) advanced 0.25% to close at $7.94. Its volatility for the week is 5.26% while…
-
Top Stories: Sprint Corporation (NYSE:S), Vimicro International Corp. (NASDAQ:VIMC), Colonial Financial Services(NASDAQ:COBK), Amedisys Inc. (NASDAQ:AMED), Union Pacific Corporation (NYSE:UNP)
Sprint Corporation (NYSE:S) has confirmed that it will finally shut down its WiMax network by November 6, 2015, verifying the leaked e-mail posted by Android Central a few days ago. Sprint Corporation (NYSE:S) in last trading activity remains unchanged to close at $6.00. Company weekly performance is -1.48% while its quarterly performance stands at -19.46%.…
-
5 Stocks Under Wall Street’s Radar: ON Semiconductor Corp. (NASDAQ:ONNN), Alcoa Inc. (NYSE:AA), ManpowerGroup Inc. (NYSE:MAN), Galmed Pharmaceuticals (NASDAQ:GLMD), Amedisys (NASDAQ:AMED)
ON Semiconductor Corporation (NASDAQ:ONNN), driving energy efficient innovation, plans to announce its financial results for the third quarter, ending September 26, 2014, after the market closes on Thursday, October 30, 2014. ON Semiconductor Corp. (NASDAQ:ONNN) in last trading activity increased 1.79% to close at $7.95. Company weekly performance is 6.85% while its quarterly performance stands…
-
Home Healthcare: BioScrip Inc (NASDAQ:BIOS), Gentiva Health Services, Inc. (NASDAQ:GTIV), Chemed Corporation (NYSE:CHE), AMED
Zacks reiterated their neutral rating on shares of BioScrip (NASDAQ:BIOS) in a research note released on Friday morning, Stock Ratings Network reports. They currently have a $8.75 target price on the stock Shares of BioScrip Inc (NASDAQ:BIOS) closed at $7.13 in last trading session. Yesterday share price of the company was traded in the range…
-
Home Healthcare Stocks: BioScrip Inc (NASDAQ:BIOS), Chemed Corporation (NYSE:CHE), Amedisys (NASDAQ:AMED), Gentiva Health Services (NASDAQ:GTIV)
BioScrip (NASDAQ:BIOS)‘s stock had its “neutral” rating reiterated by Zacks in a research note issued to investors on Friday, ARN reports. They currently have a $8.75 price objective on the stock. Zacks‘ target price suggests a potential upside of 4.67% from the company’s current price. Shares of BioScrip Inc (NASDAQ:BIOS) closed at $8.50 in last…
-
Home Healthcare Stocks: BioScrip (NASDAQ:BIOS), Chemed Corporation (NYSE:CHE), Gentiva Health Services (NASDAQ:GTIV), Amedisys Inc (NASDAQ:AMED)
BioScrip (NASDAQ:BIOS) had its target price boosted by Dougherty & Co from $8.00 to $12.00 in a report issued on Tuesday, ARN reports. They currently have a buy rating on the stock. Shares of BioScrip Inc (NASDAQ:BIOS) closed at $8.25 in last trading session. Yesterday share price of the company was traded in the range…
-
Analyst Reiterated, Upgrades and Downgrades Stocks – AMED, GE, NOV, CHH, GNRC, SNE, RIG, ARMH, CROX, EXC, BAS, PEG
Here is Monday’s top analyst reiterated, upgrades and downgrades: Credit Suisse reiterated its rating for Amedisys Inc (NASDAQ:AMED) as Underperform with a shares price target of $10. Amedisys Inc (NASDAQ:AMED) shares down -1.01% to $16.75 in current session. Credit Suisse reiterated its rating for General Electric Company (NYSE:GE) as Outperform, but increased its share price…